Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-763P is a pseudogene derived from the U6 small nuclear RNA gene family. The functional U6 small nuclear RNA (U6 snRNA) is an essential component of the spliceosome machinery responsible for pre-mRNA splicing in eukaryotes[1][3]. Multiple copies and pseudogenes of U6 snRNA genes are commonly found in vertebrate genomes and are generally considered nonfunctional “backup” sequences preserved through evolution[1]. As a pseudogene, RNU6-763P is not transcribed and/or functional in RNA splicing; it does not produce a protein nor encode a receptor, enzyme, or therapeutic molecular target. While some pseudogenes may have regulatory effects by acting as miRNA sponges or influencing gene expression, there is no established evidence that RNU6-763P has such a function[2][4]. Thus, it is not considered a therapeutic target, nor does it have specific molecular, biological, disease, or pharmacological relevance. \nThere is nothing therapeutically actionable, nor functionally unique about RNU6-763P. There is also no current evidence it serves as a research or clinical biomarker, nor does it have reported safety concerns. \n*Note on correctness:*\nRNU6-763P is not a valid therapeutic target. It is a pseudogene, not an active receptor, enzyme, or molecular target for drugs. The name is not misspelled and refers accurately to a U6 snRNA pseudogene, but it is unlikely to be actionable or relevant for therapeutic targeting. If you intended to refer to functional U6 snRNA, that is a distinct and essential non-coding RNA molecule involved in splicing, not this pseudogene[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 763, pseudogene (RNU6-763P).